匯豐銀行要求員工接種疫苗 如未有打針需自費檢測
匯豐銀行發內部郵件,要求員工需要盡快預約接種新冠疫苗,若員工不接種疫苗,需要每兩周自費檢測。而在接種首劑疫苗後60日內,未有打第二針者亦需要每兩周自費檢測。
信件中又提到,根據銀行公會最新指引,自10月1日起,未接種疫苗的員工,病毒檢測應在非辦公時間進行,而接種新冠疫苗則可以在辦公時間進行。公司只會向因醫療原因未能打針的員工支付病毒檢測費用,但必須有醫生證明。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.